{
    "clinical_study": {
        "@rank": "107667", 
        "arm_group": [
            {
                "arm_group_label": "Cocaine Administration", 
                "arm_group_type": "Experimental", 
                "description": "Subjects self administer cocaine hydrochloride in both laboratory and outpatient settings"
            }, 
            {
                "arm_group_label": "Nicotine Administation", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects self administer nicotine in both laboratory and outpatient settings"
            }, 
            {
                "arm_group_label": "Exercise", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects complete a cardiovascular exercise session in both laboratory and outpatient settings"
            }
        ], 
        "brief_summary": {
            "textblock": "This study looks to explore the feasibility, sensitivity, validity, and specificity of a\n      Remote Wireless Sensor Network (RWSN) approach to the detection of cocaine use/intoxication\n      in the inpatient human laboratory, as well as in the outpatient setting (\"real world\").\n      Lastly, we look to design an algorithm for reliably detecting cocaine use in real-world\n      settings and inference techniques for understanding the relationship between cocaine use and\n      user contexts."
        }, 
        "brief_title": "Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans", 
        "condition": "Cocaine Dependence", 
        "condition_browse": {
            "mesh_term": "Cocaine-Related Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. age 18 - 50 years,\n\n          2. voluntary, written, informed consent,\n\n          3. physically healthy by medical history, physical, neurological, ECG, and laboratory\n             examinations,\n\n          4. DSM-IV criteria for Cocaine Abuse (305.60) or Cocaine Dependence (304.20)\n\n          5. recent street cocaine use in excess of amounts to be administered in the current\n             study,\n\n          6. intravenous and/or smoked (crack/ freebase) use,\n\n          7. positive urine toxicology screen for cocaine,\n\n          8. for females, non-lactating, no longer of child-bearing potential (or agree to\n             practice effective contraception during the study), and  a negative serum pregnancy\n             (\u03b2-HCG) test.\n\n        Exclusion Criteria:\n\n          1. Other drug dependence (except nicotine) as determined by urine toxicology or\n             interview\n\n          2. < 1 year of cocaine dependence,\n\n          3. a primary major DSM-IV psychiatric diagnosis (schizophrenia, bipolar disorder, etc.),\n             unrelated to cocaine,\n\n          4. a history of significant medical (cardiovascular) or neurological illness, ie prior\n             myocardial infarction, current active symptoms of cardiovascular disease / angina,\n             evidence of cocaine-related cardiovascular symptoms, prior arrhythmias or need for\n             cardiov ascular resuscitation, neurovascular events such as transient ischemic\n             attacks, stroke, and/or seizures Parameters re: elevations in vital signs are now\n             explicitly specified under \"Safety features built into our one-day\n             self-administration paradigm).\n\n          5. current use of psychotropic and/or potentially psychoactive prescription medication,\n\n          6. seeking treatment for drug abuse/dependence (for experimental cocaine component),\n\n          7. physical or laboratory (\u03b2-HCG) evidence of pregnancy.\n\n          8. current use of any medication (prescription or over-the-counter) determined to cause\n             potential drug interactions by the study physicians."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02018263", 
            "org_study_id": "1212011268"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Nicotine Administation", 
                    "Exercise"
                ], 
                "intervention_name": "Cocaine hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Cocaine Administration", 
                    "Nicotine Administation"
                ], 
                "intervention_name": "Exercise", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "Cocaine Administration", 
                    "Exercise"
                ], 
                "intervention_name": "Nicotine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cocaine", 
                "Nicotine polacrilex", 
                "Nicotine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "December 17, 2013", 
        "location": {
            "contact": {
                "last_name": "Edward Gaiser, BA"
            }, 
            "facility": {
                "address": {
                    "city": "New Haven", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06519"
                }, 
                "name": "Connecticut Mental Health Center"
            }, 
            "investigator": {
                "last_name": "Robert T Malison, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "overall_contact": {
            "last_name": "Edward Gaiser", 
            "phone": "203-903-7795"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Instantaneous Heart Rate and Heart Rate Variability", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02018263"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Yale University", 
            "investigator_full_name": "Robert Malison", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Instantaneous Respiration Rate", 
                "safety_issue": "No", 
                "time_frame": "4 Weeks"
            }, 
            {
                "measure": "Hand-based/Foot-based Skin Conductance", 
                "safety_issue": "No", 
                "time_frame": "4 Weeks"
            }
        ], 
        "source": "Yale University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yale University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}